Edgar Filing: ZWANZIGER RON

Ownership Submission

FORM 4

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0287

Expires:

January 31, 2005

Estimated average burden hours per response...

0.5

(Print or Type Responses)

1. Name and Address of Reporting Person ^*

ZWANZIGER RON

2. Issuer Name and Ticker or Trading Symbol
INVERNESS MEDICAL INNOVATIONS INC [IMA]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

__X__ Director	_____ 10% Owner
__X__ Officer (give title below)	_____ Other (specify below)
Chairman, CEO & President

(Last)

(First)

(Middle)

51 SAWYER ROAD, SUITE 200

3. Date of Earliest Transaction (Month/Day/Year)
11/24/2008

(Street)

WALTHAM, MA 02453

4. If Amendment, Date Original Filed(Month/Day/Year)

6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

(City)

(State)

(Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1.Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	11/24/2008		P		7,000	A	$ 14.92 ⁽⁷⁾	134,830 ⁽³⁾	I	See Footnote ⁽¹⁾
Common Stock	11/24/2008		P		55,500	A	$ 15.56 ⁽¹⁶⁾	190,330 ⁽³⁾	I	See Footnote ⁽¹⁾
Common Stock	11/24/2008		P		1,500	A	$ 16.08 ⁽¹⁷⁾	191,830 ⁽³⁾	I	See Footnote ⁽¹⁾
Common Stock								1,769,902	I	See Footnote ⁽²⁾
Common Stock								770,984	D
Common Stock								664,142	I	See Footnote ⁽⁶⁾
Common Stock								2,600 ⁽³⁾	I	See Footnote ⁽⁴⁾
Common Stock								9,450 ⁽³⁾	I	See Footnote ⁽⁵⁾
Loan Interest - Senior Secured Credit Facility	11/21/2008		J⁽¹²⁾		1,000,000 ⁽⁸⁾	A	$ 750,000 ⁽¹⁰⁾	1,000,000 ⁽³⁾ ⁽⁸⁾	I	See Footnote ⁽¹⁾
Loan Interest - Junior Secured Credit Facility	11/21/2008		J⁽¹²⁾		1,000,000 ⁽⁸⁾	A	$ 730,000 ⁽¹¹⁾	1,000,000 ⁽³⁾ ⁽⁸⁾	I	See Footnote ⁽¹⁾

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security
(Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code
(Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)

6. Date Exercisable and Expiration Date
(Month/Day/Year)

7. Title and Amount of Underlying Securities
(Instr. 3 and 4)

8. Price of Derivative Security
(Instr. 5)

9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)

10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)

11. Nature of Indirect Beneficial Ownership
(Instr. 4)

Code

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

3% Senior Subordinated Convertible Notes

$ 43.98

11/24/2008

1,600,000 ⁽⁸⁾

11/24/2008

05/15/2016

Common Stock

36,380

$ 1,000,000 ⁽⁹⁾

1,600,000 ⁽⁸⁾ ⁽³⁾

See Footnote ⁽¹⁾

Series B Convertible Perpetual Preferred Stock

$ 69.32 ⁽¹⁵⁾

11/24/2008

⁽¹⁵⁾

⁽¹³⁾

Common Stock

86 ⁽¹⁴⁾

$ 103

15 ⁽³⁾

See Footnote ⁽¹⁾

Series B Convertible Perpetual Preferred Stock

$ 69.32 ⁽¹⁵⁾

11/24/2008

700

⁽¹⁵⁾

⁽¹³⁾

Common Stock

4,039 ⁽¹⁴⁾

$ 103.129

715 ⁽³⁾

See Footnote ⁽¹⁾

Series B Convertible Perpetual Preferred Stock

$ 69.32 ⁽¹⁵⁾

11/24/2008

2,000

⁽¹⁵⁾

⁽¹³⁾

Common Stock

11,540 ⁽¹⁴⁾

$ 105.756

2,715 ⁽³⁾

See Footnote ⁽¹⁾

Series B Convertible Perpetual Preferred Stock

$ 69.32 ⁽¹⁵⁾

11/24/2008

3,000

⁽¹⁵⁾

⁽¹³⁾

Common Stock

17,310 ⁽¹⁴⁾

$ 100

5,715 ⁽³⁾

See Footnote ⁽¹⁾

Series B Convertible Perpetual Preferred Stock

$ 69.32 ⁽¹⁵⁾

11/24/2008

1,000

⁽¹⁵⁾

⁽¹³⁾

Common Stock

5,770 ⁽¹⁴⁾

$ 99.995

6,715 ⁽³⁾

See Footnote ⁽¹⁾

Series B Convertible Perpetual Preferred Stock

$ 69.32 ⁽¹⁵⁾

11/24/2008

2,000

⁽¹⁵⁾

⁽¹³⁾

Common Stock

11,540 ⁽¹⁴⁾

$ 104.131

8,715 ⁽³⁾

See Footnote ⁽¹⁾

Series B Convertible Perpetual Preferred Stock

$ 69.32 ⁽¹⁵⁾

11/24/2008

1,000

⁽¹⁵⁾

⁽¹³⁾

Common Stock

5,770 ⁽¹⁴⁾

$ 101.62

9,715 ⁽³⁾

See Footnote ⁽¹⁾

Reporting Owners

Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
ZWANZIGER RON 51 SAWYER ROAD, SUITE 200 WALTHAM, MA 02453	X		Chairman, CEO & President

Signatures

/s/ Jay McNamara, Attorney in Fact		11/24/2008
^**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	These securities are owned by the Zwanziger Family Trust for the benefit of the reporting person's children. The reporting person's sister is the trustee.
(2)	These securities are owned by Zwanziger Family Ventures, LLC, an LLC managed by the reporting person and the reporting person's spouse.
(3)	The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 for any purpose.
(4)	These securities are owned by the reporting person's spouse.
(5)	These securities are owned by a private charitable foundation where the reporting person and the reporting person's spouse along with three others serve as directors on the board. The reporting person and his spouse have recused themselves from any discussion or consideration of the charitable foundation's disposition of these securities.
(6)	These securities are owned by a grantor retained annuity trust for which the reporting person is a trustee.
(7)	Represents the weighted average purchase price. Securities were acquired through approximately 66 separate purchases executed on the Transaction Date at prices ranging from $14.83 to $14.99. The reporting person hereby undertakes to provide upon request to the SEC, the issuer or any stockholder of the issuer the full information regarding the number of shares and prices at which the transaction was effected.
(8)	Represents Face Amount of Notes Acquired.
(9)	Purchased the Face Amount at $61.25 per hundred (.3875 discount) plus fees.
(10)	Purchased the Face Amount at $75 per hundred (.25 discount).
(11)	Purchased the Face amount at $73 per hundred (.27 discount).
(12)	These securities are not reportable securities for purposes of Section 16 and are being reporting solely to confirm completion of these transactions. The intent to purchase had been announced by the issuer on Form 8-K on November 19, 2008.
(13)	The Series B preferred stock has no expiration date
(14)	Each share of Series B preferred stock is convertible, based on a liquidation preference of $400.00 per share, into 5.7703 shares of common stock, plus cash in lieu of fractional shares.
(15)	Convertible at $69.32, subject to customary antidilution adjustments, if during any calendar quarter the closing price of the common stock exceeds 130% of the Series B conversion price then in effect and in certain other circumstances.
(16)	Represents the weighted average purchase price. Securities were acquired through approximately 479 separate purchases executed on the Transaction Date at prices ranging from $15.00 to $15.99. The reporting person hereby undertakes to provide upon request to the SEC, the issuer or any stockholder of the issuer the full information regarding the number of shares and prices at which the transaction was effected.
(17)	Represents the weighted average purchase price. Securities were acquired through approximately 15 separate purchases executed on the Transaction Date at prices ranging from $16.00 to $16.18. The reporting person hereby undertakes to provide upon request to the SEC, the issuer or any stockholder of the issuer the full information regarding the number of shares and prices at which the transaction was effected.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.